AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.61
-0.03 (-0.28%)
At close: Jan 16, 2026, 4:00 PM EST
10.82
+0.21 (1.98%)
After-hours: Jan 16, 2026, 6:56 PM EST
AdaptHealth Stock Forecast
Stock Price Forecast
The 5 analysts that cover AdaptHealth stock have a consensus rating of "Strong Buy" and an average price target of $13.6, which forecasts a 28.18% increase in the stock price over the next year. The lowest target is $11 and the highest is $16.
Price Target: $13.6 (+28.18%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +41.38% | Nov 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +22.53% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +22.53% | May 8, 2025 |
| Baird | Baird | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +50.80% | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +31.95% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
3.30B
from 3.26B
Increased by 1.07%
Revenue Next Year
3.51B
from 3.30B
Increased by 6.49%
EPS This Year
0.72
from 0.61
Increased by 17.89%
EPS Next Year
1.03
from 0.72
Increased by 43.44%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.4B | 3.6B | |
| Avg | 3.3B | 3.5B | |
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.7% | 10.0% | |
| Avg | 1.1% | 6.5% | |
| Low | -3.3% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 0.97 | 1.29 | ||||
| Avg | 0.72 | 1.03 | ||||
| Low | 0.57 | 0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 58.4% | 79.6% | ||||
| Avg | 17.9% | 43.4% | ||||
| Low | -6.8% | 10.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.